LIPOCINE INC. Available-for-sale Securities, Amortized Cost Basis
LIPOCINE INC. (LPCN) had Available-for-sale Securities, Amortized Cost Basis of $10.81 million as of 2019-06-30, per its 10-Q filed 2019-08-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2019-08-07
- 2019-06-30: Available-for-sale Securities, Amortized Cost Basis $10.81M.
- 2019-03-31: Available-for-sale Securities, Amortized Cost Basis $9.30M.
- 2018-12-31: Available-for-sale Securities, Amortized Cost Basis $7.17M; Available-for-sale Securities, Amortized Cost Basis as first filed $7.17M.
- 2018-09-30: Available-for-sale Securities, Amortized Cost Basis $12.08M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2019-06-30 | $10.81M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $9.30M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $7.17M 10-Q · filed 2019-08-07 | $7.17M 10-K · filed 2019-03-06 |
| 2018-09-30 | $12.08M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $18.50M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $19.22M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $18.26M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $16.41M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $11.19M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $19.87M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $21.29M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $24.13M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $20.56M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $24.10M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $24.81M 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |